Henan Lingrui Pharmaceutical Co (SHSE:600285) Ending Cash Position: ¥744 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600285 Henan Lingrui Pharmaceutical Co Ltd SHSE:600285
84 GF Score
Price ¥19.27
GF Value ¥23.85
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Henan Lingrui Pharmaceutical Co Ending Cash Position?

Henan Lingrui Pharmaceutical Co SHSE:600285 +0.57% 84 Ending Cash Position is ¥744 Mil as of Jun. 2026. GuruFocus rates SHSE:600285 with a GF Score™ of 84/100 and a GF Value™ of ¥23.85 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Henan Lingrui Pharmaceutical Co's Ending Cash Position for the quarter that ended in Jun. 2026 was ¥744 Mil.

Henan Lingrui Pharmaceutical Co's quarterly Ending Cash Position increased from Dec. 2025 (¥383 Mil) to Mar. 2026 (¥453 Mil) and increased from Mar. 2026 (¥453 Mil) to Jun. 2026 (¥744 Mil).

Henan Lingrui Pharmaceutical Co's annual Ending Cash Position declined from Dec. 2023 (¥1,490 Mil) to Dec. 2024 (¥1,228 Mil) and declined from Dec. 2024 (¥1,228 Mil) to Dec. 2025 (¥383 Mil).

Henan Lingrui Pharmaceutical Co Ending Cash Position Related Terms

Henan Lingrui Pharmaceutical Co Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Henan Lingrui Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Henan Lingrui Pharmaceutical Co Ending Cash Position Chart

Henan Lingrui Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 801.24 1,179.29 1,490.28 1,228.38 382.84

Henan Lingrui Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 532.32 459.66 382.84 452.89 743.70
SHSE:600285
84GF Score
Henan Lingrui Pharmaceutical Co Ltd SHSE:600285
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Henan Lingrui Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Henan Lingrui Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1228.378+-845.534
=383

Henan Lingrui Pharmaceutical Co's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=452.893+290.806
=744

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of ¥744 Mil mean?
Henan Lingrui Pharmaceutical Co (SHSE:600285) has a Ending Cash Position of ¥744 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Henan Lingrui Pharmaceutical Co and its competitors.
Is Henan Lingrui Pharmaceutical Co's Ending Cash Position too high?
Henan Lingrui Pharmaceutical Co's current Ending Cash Position is ¥744 Mil. Overall, Henan Lingrui Pharmaceutical Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Henan Lingrui Pharmaceutical Co's Ending Cash Position compare to ZTS?
Henan Lingrui Pharmaceutical Co's Ending Cash Position of ¥744 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Henan Lingrui Pharmaceutical Co and its competitors. Henan Lingrui Pharmaceutical Co's current Ending Cash Position is ¥744 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henan Lingrui Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co (SHSE:600285) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥23.85, compared to a current price of ¥19.27 — trading 19.2% below its estimated fair value. The current Ending Cash Position is ¥744 Mil. Henan Lingrui Pharmaceutical Co's overall GF Score™ is 84/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Henan Lingrui Pharmaceutical Co (SHSE:600285), the current Ending Cash Position is ¥744 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Henan Lingrui Pharmaceutical Co (SHSE:600285) Overvalued in 2026?

Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥19.27 is trading 19.2% below its estimated GF Value™ of ¥23.85. GuruFocus considers Henan Lingrui Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:600285:

  • Ending Cash Position: ¥744 Mil
  • GF Value™: ¥23.85 vs. price of ¥19.27 (19.2% below fair value)
  • GF Score™: 84/100 with 3 warning signs

No single metric tells the full story. See the SHSE:600285 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Henan Lingrui Pharmaceutical Co Business Description

Address No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.
84GF Score

Get the complete analysis for SHSE:600285

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥19.27
Price
¥23.85
GF Value